CAPILLARY - Capillary Tech.

Capillary Technologies India Limited has scheduled its earnings conference call for the fourth quarter and full fiscal year ended March 31, 2026. The call is slated for Wednesday, May 6, 2026, at 4:00 P.M. IST. This session follows the official announcement of the company's financial results and provides a platform for management to discuss performance with analysts and investors. Market participants will be looking for updates on the company's growth trajectory and operational margins.

• Earnings conference call for Q4 and FY 2025-26 scheduled for May 6, 2026, at 4:00 PM IST.
• The call will discuss financial results for the quarter and year ended March 31, 2026.
• Registration link for the event has been provided to institutional investors and analysts.
• Sunil Jain, Head of Corporate Development, is the designated contact for investor relations queries.

Capillary Technologies India Limited has allotted 64,680 equity shares of ₹ 2/- each following the exercise of options under its 2021 ESOP scheme. The allotment was approved by the Nomination and Remuneration Committee via circular resolution on April 16, 2026. This action increases the company's total issued share capital to ₹ 15.89 crore, comprising 7,94,71,983 shares. The new shares rank pari-passu with existing equity shares and were issued at an exercise price of ₹ 2/- per share.

• Allotment of 64,680 equity shares of face value ₹ 2/- each upon exercise of vested options
• Shares issued under the Capillary Employees Stock Option Scheme – 2021
• Total post-issue share capital increased to 7,94,71,983 equity shares
• Exercise price for the shares was set at ₹ 2/- per share with nil premium

Capillary Technologies India Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirmed that no dematerialization requests were received during the quarter ended March 31, 2026. This is due to the fact that 100% of the company's shares are already held in electronic mode. This filing is a standard regulatory requirement and indicates no change in the shareholding structure from physical to electronic form.

• Compliance certificate submitted for the quarter ended March 31, 2026
• Zero demat requests were processed during the reporting period
• 100% of company shares are confirmed to be held in electronic mode only
• Certificate issued by Registrar and Share Transfer Agent MUFG Intime India Private Limited

Aneesh Reddy Boddu, on behalf of the promoter group of Capillary Technologies India Limited, has filed a disclosure under Regulation 31(4) of SEBI (SAST) Regulations. The filing confirms that no members of the promoter group or persons acting in concert have made any new encumbrances on their shares during the financial year ended March 31, 2026. This routine annual declaration ensures that all share pledges, if any, have already been disclosed and no fresh leverage was created against promoter holdings in the specified period.

• Compliance filing under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
• Covers the full financial year period ending March 31, 2026.
• Confirms zero new direct or indirect encumbrances by promoters during the year.
• Declaration includes major promoters such as Aneesh Reddy Boddu and Capillary Technologies International Pte. Ltd.

Capillary Technologies has announced the grant of 6,563 stock options to eligible employees under its ESOP Plan 2021. Each option is convertible into one equity share of face value ₹2 at an exercise price of ₹475. This price represents a 19.85% discount to the 90-day volume-weighted average price. The options will vest over a period of four years, aimed at long-term employee retention and alignment with shareholder interests.

• Grant of 6,563 stock options to eligible employees under the ESOP Plan 2021
• Exercise price set at ₹475 per option, a 19.85% discount to fair market value
• Vesting period of four years with an exercise period up to 12 years from listing
• Each option entitles the holder to one equity share of face value ₹2

Capillary Technologies India Limited has announced the closure of its trading window effective April 01, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's audited financial results for the quarter and year ending March 31, 2026. The window will remain closed until 48 hours after the results are officially declared to the stock exchanges. This is a standard regulatory procedure for listed companies to prevent insider trading during the sensitive period before earnings releases.

• Trading window closure starts on Wednesday, April 01, 2026.
• Closure is related to the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
• The window will reopen 48 hours after the announcement of the financial results.
• The restriction applies to all Designated Persons, their immediate relatives, and other insiders of the company.

Capillary Technologies has successfully passed a special resolution to extend its 2021 Employee Stock Option Scheme (ESOP) to employees of its Indian and overseas subsidiaries. The resolution was approved with an 86.48% majority of the total 56.27 million votes polled. Notably, there was significant resistance from institutional investors, with 55.9% of their votes (7.61 million shares) cast against the proposal. The promoter group and non-institutional public investors voted almost entirely in favor of the extension.

• Special resolution passed with 86.48% total votes in favor and 13.52% against.
• Institutional investors showed significant dissent, with 55.9% of their polled votes against the resolution.
• Promoter group cast 41.19 million votes, representing 100% support from their side.
• The extension covers employees of all subsidiary companies, both in India and overseas.
• Total voting participation stood at 70.95% of the total outstanding shares.

Capillary Technologies India Limited has allotted 95,530 equity shares of face value ₹2 each following the exercise of options under its ESOP Plan 2021. The allotment was approved by the Nomination and Remuneration Committee via a circular resolution on March 12, 2026. This move increases the company's total issued share capital to 79,407,303 equity shares. The new shares are identical to existing shares and will rank pari passu in all respects.

• Allotment of 95,530 equity shares of ₹2 each fully paid-up
• Exercise price for the allotted shares was set at ₹2 per share
• Total issued share capital post-allotment stands at ₹15,88,14,606
• Total number of issued shares increased to 79,407,303
• Allotment conducted under the Capillary Employees Stock Option Scheme – 2021

Capillary Technologies India Limited has released the audio recording of its investor and analyst call held on February 27, 2026. This disclosure is a standard regulatory requirement under SEBI Listing Regulations to ensure transparency for all shareholders. The recording contains the management's discussion on the company's performance and strategic direction. Investors can access the full audio via the company's official investor relations portal.

• Audio recording of the investor call held on February 27, 2026, is now publicly available.
• Disclosure made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• The recording link is hosted on the official Capillary Technologies website under the 'Investors' section.
• Provides a platform for shareholders to hear management commentary and analyst Q&A sessions.

Capillary Technologies has issued a clarification regarding its ESOP 2021 scheme following feedback from proxy advisors. The company has specified that the exercise price for options granted post-listing will be subject to a maximum discount of 20% to the 90-day Volume Weighted Average Price (VWAP). This clarification aims to address concerns regarding arbitrary pricing and ensures that the scheme is market-linked. The resolution under discussion involves extending these ESOP benefits to employees of both Indian and overseas subsidiaries.

• Exercise price for ESOP 2021 grants capped at a maximum 20% discount to the 90-day VWAP.
• The 90-day VWAP will be calculated based on the stock exchange with the highest trading volume.
• Minimum exercise price for options is set at the face value of INR 2 per share.
• Clarification follows feedback from proxy advisors regarding lack of transparency in the original Postal Ballot Notice.
• The scheme covers employees of subsidiary companies across both domestic and international jurisdictions.